13.10.2012 • News

Applikon Biotechnology Starts Construction of New Facility in Delft

Applikon Biotechnology, a private Dutch company specialized in the development, manufacture and supply of bioreactor systems for both research and production use, has started the construction of a new facility on the high-tech science park Technolopis in Delft. The building with offices, laboratories, a workshop and warehouse will accommodate approximately 100 people.

 

 

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.